Immunosuppression for neural xenografts: A comparison of cyclosporin and anti-CD25 monoclonal antibody

Journal of Neurosurgery

Volumn 91, Issue 1, 1999, Pages 109-113

  Honey, Christopher R ^a   Shen, Hao ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

CD25; Dopamine; Immunosuppression; Neural transplantation; Xenograft

Indexed keywords

CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DENERVATION; FETUS; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; MALE; MOUSE; NERVE TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT OUTCOME; XENOGRAFT;

EID: 0032749609     PISSN: 00223085     EISSN: None     Source Type: Journal    
DOI: 10.3171/jns.1999.91.1.0109     Document Type: Article

References (33)

1. Barclay AN: The localization of populations of lymphocytes defined by monoclonal antibodies in rat lymphoid tissues. Immunology 42:593-600, 1981
2. Bennett WM: Drug nephrotoxicity: an overview. Ren Fail 19: 221-224, 1997
3. Berden JHM, Hoitsma AJ, Merx JL, et al: Severe central-nervous-system toxicity associated with cyclosporin. Lancet 1: 219-220, 1985 (Letter)
4. Borlongan CV, Freeman TB, Scorcia TA, et al: Cyclosporine-A increases spontaneous and dopamine agonist-induced locomotor behavior in normal rats. Cell Transplant 4:65-73, 1995
5. Borlongan CV, Stahl CE, Cameron DF, et al: CNS immunological modulation of neural graft rejection and survival. Neurol Res 18:297-304, 1996
6. Brundin P, Nilsson OG, Gage FH, et al: Cyclosporin A increases survival of cross-species intrastriatal grafts of embryonic dopamine-containing neurons. Exp Brain Res 60:204-208, 1985
7. Brundin P, Widner H, Nilsson OG, et al: Intracerebral xenografts of dopamine neurons: the role of immunosuppression and the blood-brain barrier. Exp Brain Res 75:195-207, 1989
8. Cosimi AB: Future of monoclonal antibodies in solid organ transplantation. Dig Dis Sci 40:65-72, 1995
9. Deacon T, Schumacher J, Dinsmore J, et al: Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease. Nature Med 3:350-353, 1997
10. Defer GL, Geny C, Ricolfi F, et al: Long-term outcome of unilaterally transplanted parkinsonian patients. I. Clinical approach. Brain 119:41-50, 1996
11. Duan WM, Brundin P, Grasbon-Frodl EM, et al: Methylprednisolone prevents rejection of intrastriatal grafts of xenogeneic embryonic neural tissue in adult rats. Brain Res 712:199-212, 1996
12. Famiglio L, Racusen L, Fivush B, et al: Central nervous system toxicity of cyclosporine in a rat model. Transplantation 48: 316-321, 1989
13. Freeman TB, Olanow CW, Hauser RA, et al: Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 38:379-388, 1995
14. Gold BG, Storm-Dickerson T, Austin DR: The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury. Rester Neurol Neurosci 6:287-296, 1994
15. Ho S, Clipstone N, Timmermann L, et al: The mechanism of action of cyclosporin A and FK506. Clin Immunol Immunopathol 80:S40-S45, 1996
16. Honey CR, Charlton HM, Wood KJ: Rat brain xenografts reverse hypogonadism in mice immunosuppressed with anti-CD4 monoclonal antibody. Exp Brain Res 85:149-152, 1991
17. Honey CR, Clarke DJ, Dallman MJ, et al: Human neural graft function in rats treated with anti-interleukin II receptor anti-body. NeuroReport 1:247-249, 1991
18. Ledbetter JA, Herzenberg LA: Xenogeneic monoclonal anti-bodies to mouse lymphoid differentiation antigens. Immunol Rev 47:63-90, 1979
19. Medawar PB: Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol 29:58-69, 1948
20. Okura Y, Tanaka R, Ono K, et al: Treatment of rat hemiparkinson model with xenogeneic neural transplantation: tolerance induction by anti-T-cell antibodies. J Neurosci Res 48: 385-396, 1997
21. Pakzaban P, Deacon TW, Burns LH, et al: A novel mode of immunoprotection of neural xenotransplants: masking of donor major histocompatibility complex class I enhances transplant survival in the central nervous system. Neuroscience 65: 983-996, 1995
22. Pakzaban P, Isacson O: Neural xenotransplantation: reconstruction of neuronal circuitry across species barriers. Neuroscienee 62:989-1001, 1994
23. Ryba M, Grieb P, Janczewski WA, et al: Survival and maturation of heterotopic fetal brain stem xenografts after treatment with 2-chlorodeoxyadenosine and cyclosporine A. Acta Neurobiol Exp 55:259-270, 1995
24. Sakai K, Date I, Yoshimoto Y, et al: The effect of a new immunosuppressive agent, FK-506, on xenogeneic neural transplantation in rodents. Brain Res 565:167-170, 1991
25. Sloan DJ, Wood MJ, Charlton HM: The immune response to intracerebral neural grafts. Trends Neurosci 14:341-346, 1991
26. Tellides G, Dallman MJ, Morris PJ: Mechanism of action of interleukin-2 receptor (IL-2R) monoclonal antibody (MAb) therapy: target cell depletion or inhibition of function? Transplant Proc 21:997-998, 1989
27. Tellides G, Dallman MJ, Morris PJ: Synergistic interaction of cyclosporine A with interleukin 2 receptor monoclonal anti-body therapy. Transplant Proc 20 (Suppl 2):202-206, 1988
28. Ungerstedt U: Postsynaptic supersensitivity after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol Scand Suppl 367:69-93, 1971
29. Ungerstedt U, Arbuthnott GW: Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res 24:485-493, 1970
30. Widner H, Brundin P: Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis. Brain Res Rev 472:287-324, 1988
31. Widner H, Brundin P, Rehncrona S, et al: Transplanted allogeneic fetal dopamine neurons survive and improve motor function in idiopathic Parkinson's disease. Transplant Proc 23:793-795, 1991
32. Wood MJ, Sloan DJ, Dallman MJ, et al: A monoclonal anti-body to the interleukin-2 receptor enhances the survival of neural allografts: a time course study. Neuroscience 49:409-413, 1992
33. Zhou J, Date I, Sakai K, et al: Suppression of immunorejection against rat fetal dopaminergic neurons in a mouse brain by 15-deoxyspergualin. Brain Res 621:155-160, 1993